Cargando…

High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution

Protein glycosylation can impact the efficacy and safety of biotherapeutics and therefore needs to be well characterized and monitored throughout the drug product life cycle. Glycosylation is commonly assessed by fluorescent labeling of released glycans, which provides comprehensive information of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ximo, Reed, Corey E., Birdsall, Robert E., Yu, Ying Qing, Chen, Weibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372583/
https://www.ncbi.nlm.nih.gov/pubmed/32458729
http://dx.doi.org/10.1177/2472630320922803
_version_ 1783561343751684096
author Zhang, Ximo
Reed, Corey E.
Birdsall, Robert E.
Yu, Ying Qing
Chen, Weibin
author_facet Zhang, Ximo
Reed, Corey E.
Birdsall, Robert E.
Yu, Ying Qing
Chen, Weibin
author_sort Zhang, Ximo
collection PubMed
description Protein glycosylation can impact the efficacy and safety of biotherapeutics and therefore needs to be well characterized and monitored throughout the drug product life cycle. Glycosylation is commonly assessed by fluorescent labeling of released glycans, which provides comprehensive information of the glycoprofile but can be resource-intensive regarding sample preparation, data acquisition, and data analysis. In this work, we evaluate a comprehensive solution from sample preparation to data reporting using a liquid chromatography–mass spectrometry (LC-MS)-based analytical platform for increased productivity in released glycan analysis. To minimize user intervention and improve assay robustness, a robotic liquid handling platform was used to automate the release and labeling of N-glycans within 2 h. To further increase the throughput, a 5 min method was developed on a liquid chromatography–fluorescence–mass spectrometry (LC-FLR-MS) system using an integrated glycan library based on retention time and accurate mass. The optimized method was then applied to 48 released glycan samples derived from six batches of infliximab to mimic comparability testing encountered in the development of biopharmaceuticals. Consistent relative abundance of critical species such as high mannose and sialylated glycans was obtained for samples within the same batch (mean percent relative standard deviation [RSD] = 5.3%) with data being acquired, processed, and reported in an automated manner. The data acquisition and analysis of the 48 samples were completed within 6 h, which represents a 90% improvement in throughput compared with conventional LC-FLR-based methods. Together, this workflow facilitates the rapid screening of glycans, which can be deployed at various stages of drug development such as process optimization, bioreactor monitoring, and clone selections, where high-throughput and improved productivity are particularly desired.
format Online
Article
Text
id pubmed-7372583
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-73725832020-08-13 High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution Zhang, Ximo Reed, Corey E. Birdsall, Robert E. Yu, Ying Qing Chen, Weibin SLAS Technol Original Research Protein glycosylation can impact the efficacy and safety of biotherapeutics and therefore needs to be well characterized and monitored throughout the drug product life cycle. Glycosylation is commonly assessed by fluorescent labeling of released glycans, which provides comprehensive information of the glycoprofile but can be resource-intensive regarding sample preparation, data acquisition, and data analysis. In this work, we evaluate a comprehensive solution from sample preparation to data reporting using a liquid chromatography–mass spectrometry (LC-MS)-based analytical platform for increased productivity in released glycan analysis. To minimize user intervention and improve assay robustness, a robotic liquid handling platform was used to automate the release and labeling of N-glycans within 2 h. To further increase the throughput, a 5 min method was developed on a liquid chromatography–fluorescence–mass spectrometry (LC-FLR-MS) system using an integrated glycan library based on retention time and accurate mass. The optimized method was then applied to 48 released glycan samples derived from six batches of infliximab to mimic comparability testing encountered in the development of biopharmaceuticals. Consistent relative abundance of critical species such as high mannose and sialylated glycans was obtained for samples within the same batch (mean percent relative standard deviation [RSD] = 5.3%) with data being acquired, processed, and reported in an automated manner. The data acquisition and analysis of the 48 samples were completed within 6 h, which represents a 90% improvement in throughput compared with conventional LC-FLR-based methods. Together, this workflow facilitates the rapid screening of glycans, which can be deployed at various stages of drug development such as process optimization, bioreactor monitoring, and clone selections, where high-throughput and improved productivity are particularly desired. SAGE Publications 2020-05-27 2020-08 /pmc/articles/PMC7372583/ /pubmed/32458729 http://dx.doi.org/10.1177/2472630320922803 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Zhang, Ximo
Reed, Corey E.
Birdsall, Robert E.
Yu, Ying Qing
Chen, Weibin
High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution
title High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution
title_full High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution
title_fullStr High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution
title_full_unstemmed High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution
title_short High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution
title_sort high-throughput analysis of fluorescently labeled n-glycans derived from biotherapeutics using an automated lc-ms-based solution
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372583/
https://www.ncbi.nlm.nih.gov/pubmed/32458729
http://dx.doi.org/10.1177/2472630320922803
work_keys_str_mv AT zhangximo highthroughputanalysisoffluorescentlylabelednglycansderivedfrombiotherapeuticsusinganautomatedlcmsbasedsolution
AT reedcoreye highthroughputanalysisoffluorescentlylabelednglycansderivedfrombiotherapeuticsusinganautomatedlcmsbasedsolution
AT birdsallroberte highthroughputanalysisoffluorescentlylabelednglycansderivedfrombiotherapeuticsusinganautomatedlcmsbasedsolution
AT yuyingqing highthroughputanalysisoffluorescentlylabelednglycansderivedfrombiotherapeuticsusinganautomatedlcmsbasedsolution
AT chenweibin highthroughputanalysisoffluorescentlylabelednglycansderivedfrombiotherapeuticsusinganautomatedlcmsbasedsolution